calcium glubionate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4842	12569-38-9

Description:

Molecule	Description
Synonyms: calcium glubionate Neo-Calglucon calcium glubionate monohydrate	Molecular weight: 610.53 Formula: C18H34CaO20 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 220.43 ALOGS: ROTB: None

Molecule

Description

Synonyms:

calcium glubionate
Neo-Calglucon
calcium glubionate monohydrate

Molecular weight: 610.53
Formula: C18H34CaO20
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 220.43
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Liver injury	827.11	169.19	429	25256	60091	63403246
Psoriatic arthropathy	674.38	169.19	434	25251	91086	63372251
Glossodynia	423.79	169.19	437	25248	178439	63284898
Pemphigus	405.13	169.19	432	25253	183294	63280043
Systemic lupus erythematosus	372.91	169.19	440	25245	208478	63254859
Hand deformity	351.44	169.19	375	25310	159082	63304255
Arthropathy	342.74	169.19	447	25238	234345	63228992
Duodenal ulcer perforation	330.23	169.19	277	25408	86932	63376405
Wound	330.21	169.19	367	25318	162896	63300441
Rheumatic fever	284.18	169.19	191	25494	42920	63420417
Blood cholesterol increased	282.60	169.19	262	25423	93770	63369567
Rheumatoid arthritis	281.97	169.19	424	25261	253395	63209942
Fibromyalgia	274.99	169.19	241	25444	80179	63383158
Contraindicated product administered	269.81	169.19	383	25302	217265	63246072
Product use issue	267.41	169.19	384	25301	220136	63243201
Helicobacter infection	254.87	169.19	246	25439	92539	63370798
Rheumatoid factor positive	247.44	169.19	232	25453	84174	63379163
Pericarditis	239.08	169.19	280	25405	131299	63332038
Type 2 diabetes mellitus	237.78	169.19	201	25484	63667	63399670
Abdominal discomfort	228.79	169.19	440	25245	320445	63142892
Alopecia	220.32	169.19	446	25239	337090	63126247
Anti-cyclic citrullinated peptide antibody positive	205.57	169.19	244	25441	115968	63347369
Discomfort	204.92	169.19	293	25392	167081	63296256
Injury	204.46	169.19	196	25489	73051	63390286
Facet joint syndrome	197.46	169.19	97	25588	12041	63451296
Swollen joint count increased	187.00	169.19	138	25547	35916	63427421
Blister	185.57	169.19	245	25440	129569	63333768
Maternal exposure during pregnancy	184.65	169.19	324	25361	219738	63243599
Peripheral venous disease	180.74	169.19	99	25586	15378	63447959
Swelling	173.69	169.19	359	25326	275019	63188318
Anti-cyclic citrullinated peptide antibody	169.61	169.19	73	25612	6685	63456652

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Liver injury	385.57	182.17	209	18098	56405	79669676
Duodenal ulcer perforation	376.23	182.17	217	18090	65994	79660087
Psoriatic arthropathy	335.86	182.17	214	18093	77785	79648296
Fibromyalgia	329.02	182.17	197	18110	64143	79661938
Blood cholesterol increased	317.18	182.17	212	18095	83508	79642573
Rheumatic fever	311.21	182.17	145	18162	28380	79697701
Pemphigus	297.51	182.17	218	18089	99364	79626717
Glossodynia	297.00	182.17	221	18086	103116	79622965
Helicobacter infection	294.47	182.17	189	18118	69515	79656566
Hand deformity	291.43	182.17	219	18088	103700	79622381
Pericarditis	268.82	182.17	209	18098	104027	79622054
Systemic lupus erythematosus	261.74	182.17	219	18088	120930	79605151
Rheumatoid factor positive	249.60	182.17	161	18146	59678	79666403
Wound	246.80	182.17	208	18099	115971	79610110
Anti-cyclic citrullinated peptide antibody positive	232.51	182.17	175	18132	82968	79643113
Facet joint syndrome	231.98	182.17	90	18217	11212	79714869
Type 2 diabetes mellitus	231.62	182.17	151	18156	56971	79669110
Swollen joint count increased	226.89	182.17	109	18198	22818	79703263
Folliculitis	218.69	182.17	144	18163	55236	79670845
Blister	217.65	182.17	196	18111	119280	79606801
Arthropathy	204.99	182.17	227	18080	176884	79549197
Peripheral venous disease	202.26	182.17	90	18217	15819	79710262
Lip dry	201.73	182.17	89	18218	15329	79710752
Discomfort	199.66	182.17	191	18116	125426	79600655
Deep vein thrombosis postoperative	190.52	182.17	77	18230	10675	79715406
Injury	188.06	182.17	150	18157	77346	79648735
Anti-cyclic citrullinated peptide antibody	184.72	182.17	64	18243	5788	79720293
Synovitis	184.46	182.17	199	18108	150535	79575546

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A12AA02	ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS CALCIUM Calcium

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hypocalcemia	indication	5291005

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
3CF7K0SD0Q	UNII
D03294	KEGG_DRUG
4020041	VUID
N0000179144	NUI
4020041	VANDF
C0061347	UMLSCUI
CHEMBL2104594	ChEMBL_ID
CHEMBL2219740	ChEMBL_ID
18940190	PUBCHEM_CID
2890	INN_ID
C042131	MESH_SUPPLEMENTAL_RECORD_UI
218656	RXNORM
4335	MMSL
5173	MMSL
8444	MMSL
d03817	MMSL
000775	NDDF
32445001	SNOMEDCT_US

Pharmaceutical products:

None